title: Long-term antiretroviral combination therapy including lamivudine in HIV-1 infected women during pregnancy.
authors.forename: T A
authors.initials: TA
authors.lastname: Grubert
authors.forename: U
authors.initials: U
authors.lastname: Wintergerst
authors.forename: R
authors.initials: R
authors.lastname: Lutz-Friedrich
authors.forename: B H
authors.initials: BH
authors.lastname: Belohradsky
authors.forename: B
authors.initials: B
authors.lastname: Rolinski
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D019259:Lamivudine / Q000097:blood / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000821:virology; D018894:Reverse Transcriptase Inhibitors / Q000097:blood / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine